+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Recent advances in proteomics and cancer biomarker discovery



Recent advances in proteomics and cancer biomarker discovery



Clinical Medicine. Oncology 2: 63-72



Early diagnosis and prevention is a key factor in reducing the mortality and morbidity of cancer. However, currently available screening tools lack enough sensitivity for early diagnosis. It is important to develop noninvasive techniques and methods that can screen and identify asymptomatic patients who have cancer. Biomarkers of cancer status can also serve as powerful tools in monitoring the course of cancer and in determining the efficacy and safety of novel therapies. Thus, discovery of novel specific biomarkers are needed that may provide informative clues for early diagnosis and treatment of cancer. Recently, remarkable progress has been made in the development of new proteomics technology. The progress that has been made in this field is helpful in identifying biomarkers that can be used for early diagnosis of cancer and improving the understanding of the molecular etiological mechanism of cancer. This article describes the current state of the art in this field.

(PDF emailed within 1 workday: $29.90)

Accession: 055398499

Download citation: RISBibTeXText

PMID: 21892267


Related references

Lung cancer proteomics: recent advances in biomarker discovery. International Journal of Proteomics 2011: 726869-726869, 2012

Recent advances in biomarker discovery in solid organ transplant by proteomics. Expert Review of Proteomics 8(6): 705-715, 2012

Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery. Briefings in Functional Genomics and Proteomics 4(1): 16-26, 2005

Advances in membrane proteomics and cancer biomarker discovery: current status and future perspective. Proteomics 12(19-20): 3085-3104, 2013

Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma. Expert Review of Proteomics 14(4): 373-386, 2017

The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification. Expert Review of Proteomics 13(1): 99-114, 2016

Proteomics: advances in biomarker discovery. Expert Review of Proteomics 5(1): 21-23, 2008

Advances in top-down proteomics for disease biomarker discovery. Journal of Proteomics 74(7): 920-934, 2011

Advances in proximal fluid proteomics for disease biomarker discovery. Journal of Proteome Research 9(12): 6091-6100, 2011

Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. Proteomics 11(4): 709-720, 2011

Proteomics for cancer biomarker discovery. Clinical Chemistry 48(8): 1160-1169, 2002

Recent advances in capillary electrophoresis for biomarker discovery. Journal of Separation Science 30(2): 192-201, 2007

Proteomics in the forefront of cancer biomarker discovery. Journal of Proteome Research 4(4): 1098-1103, 2005

Quantitative proteomics for cancer biomarker discovery. Combinatorial Chemistry and High Throughput Screening 15(3): 221-231, 2012

Proteomics in prostate cancer biomarker discovery. Expert Review of Proteomics 7(1): 93-102, 2010